92 related articles for article (PubMed ID: 1788808)
1. [The effect of specific transfusion therapy on the level of circulating immune complexes in hemophilia patients].
Andreeva TA; Fedorova ZD; Khanin TM; Klimova NI
Ter Arkh; 1991; 63(7):50-3. PubMed ID: 1788808
[TBL] [Abstract][Full Text] [Related]
2. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
[TBL] [Abstract][Full Text] [Related]
3. Immune complex levels and HBs-antigenaemia in healthy Nigerians and patients with liver diseases.
Okerengwo AA; Atoba MA
Afr J Med Med Sci; 1992 Dec; 21(2):35-8. PubMed ID: 1308079
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes and complement levels in hemophilic children.
Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
[TBL] [Abstract][Full Text] [Related]
5. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
[TBL] [Abstract][Full Text] [Related]
6. Coagulation factor therapy for hemophilia: relation to hepatitis B and to liver function.
Card RT; Dusevic M; Lukie BE
Can Med Assoc J; 1982 Jan; 126(1):34-6. PubMed ID: 7059871
[TBL] [Abstract][Full Text] [Related]
7. [Immune disorders in hemophiliac patients].
Kachorovskiĭ BV; Loginskiĭ VE; Vygovskaia IaI; Rudenko VP
Ter Arkh; 1987; 59(10):81-5. PubMed ID: 3124282
[TBL] [Abstract][Full Text] [Related]
8. [Incidence of hepatitis B in hemophilia patients].
Thoms J; Berles R; Syrbe G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):523-9. PubMed ID: 2446993
[TBL] [Abstract][Full Text] [Related]
9. [Acute viral hepatitis in the Florence area: II. Immunologic study].
Passaleva A; Massai G; Leoncini F; Dionisio D; Paci P; Ricci M
Boll Ist Sieroter Milan; 1983 Jul; 62(3):224-37. PubMed ID: 6639776
[TBL] [Abstract][Full Text] [Related]
10. Immunological abnormalities in HIV-free haemophiliacs.
Fukushima Y; Makino M; Fukutake K; Okuyama K; Ueda M; Yorifugi H; Mimaya J; Fujimaki M; Komuro K
J Clin Lab Immunol; 1993; 40(4):173-80. PubMed ID: 7707343
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
Meili EO
Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
[TBL] [Abstract][Full Text] [Related]
12. Transfusion support for haemophiliacs.
Allain JP
Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
[No Abstract] [Full Text] [Related]
13. Evaluation of circulating immune complexes in cutaneous diseases associated with immune disorders.
Fernández Bussy R; Crisci CD; Fiorenza G; Bertoya N
Allergol Immunopathol (Madr); 1990; 18(1):47-52. PubMed ID: 2143349
[TBL] [Abstract][Full Text] [Related]
14. [Circulating immune complex and complement (C3) in a course of pulmonary tuberculosis].
Dubaniewicz A; Sztaba-Kania M
Pol Merkur Lekarski; 2002 Jun; 12(72):491-5. PubMed ID: 12362668
[TBL] [Abstract][Full Text] [Related]
15. Immune complexes in hemophilia.
Poskitt TR; Poskitt PK; Bean CA; Arkel YS
Am J Hematol; 1981 Sep; 11(2):147-52. PubMed ID: 6795922
[TBL] [Abstract][Full Text] [Related]
16. Significance of circulating immune complexes in pulmonary tuberculosis.
Samuel AM; Ashtekar MD; Ganatra RD
Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
[TBL] [Abstract][Full Text] [Related]
18. The effects of ageing on the immune response to Schistosoma haematobium and hookworm by measuring circulating immune complexes, C3, IgG, IgA and IgM levels in residents of Omi dam area of Kogi State, Nigeria.
Oyeyinka GO; Awogun IA; Akande TM; Awarun JA; Arinola OG; Salimonu LS
Afr J Med Med Sci; 2003 Sep; 32(3):263-7. PubMed ID: 15030085
[TBL] [Abstract][Full Text] [Related]
19. Detection of mycobacterial antigen in circulating immune complexes in patients with childhood tuberculosis.
Srivastava L; Srivastava VK
Indian J Pathol Microbiol; 1999 Oct; 42(4):405-9. PubMed ID: 11127369
[TBL] [Abstract][Full Text] [Related]
20. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
Schimpf K; Schwarz P; Kunschak M
Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
